294 results on '"Ramanathan, Muthalagu"'
Search Results
2. The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant—a CIBMTR study
3. Outcomes of older adults undergoing allogeneic stem cell transplant with post-transplant cyclophosphamide.
4. Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses
5. Natural history of clonal haematopoiesis seen in real‐world haematology settings.
6. Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study
7. Trial in Progress: An Open-Label, Multi-Center Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) and Propranolol with and without G-CSF for the Mobilization of Stem Cells in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
8. Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting
9. Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
10. Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival
11. Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns
12. Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes
13. Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma
14. Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden
15. Post-Transplant Outcomes in High-Risk Compared with Non–High-Risk Multiple Myeloma: A CIBMTR Analysis
16. Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT
17. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
18. Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies
19. Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation
20. The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant—a CIBMTR study
21. Prognostic Discrimination within a Heterogeneous Population of TP53-Aberrant Myelodysplastic Syndromes and Acute Myeloid Leukemia
22. Impaired Clearance of DNMT3A/TET2/ASXL1-Mutant Clones with Hypomethylating Agent or Intensive Induction Chemotherapy for Myelodysplastic Syndrome and Acute Myeloid Leukemia
23. Natural History of Patients with Clonal Hematopoiesis Seen in Hematology Clinics
24. Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation
25. Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning
26. Allotransplantation for Patients Age ≥40 Years with Non-Hodgkin Lymphoma: Encouraging Progression-Free Survival
27. Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
28. AML-360 Mutational Landscape and Survival Outcomes of Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Harboring Cohesin Complex Mutations
29. Mutational Landscape and Survival Outcomes of Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Harboring Cohesin Complex Mutations
30. Treatment of Acute Graft-versus-Host Disease in Liver Transplant Recipients
31. The Incidence and Impact of Clostridioides Difficile Infection (CDI) on Outcomes after Allogeneic Hematopoietic Cell Transplant (alloHCT) - a CIBMTR Study
32. Clinico-genomic profiling and clonal dynamic modeling of TP53-aberrant myelodysplastic syndrome and acute myeloid leukemia
33. Frameshift Mutations in Leukemia Associated Genes Correlate with Superior Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant for De Novo Acute Myeloid Leukemia Compared to Other Types of Mutations
34. Myeloid Derived Suppressor Cells and Their Potential Impact on Minimal Residual Disease Status and Disease Response in a Cohort of Patients with Plasma Cell Dyscrasias
35. Nonengraftment Haploidentical Cellular Immunotherapy for Refractory Malignancies: Tumor Responses without Chimerism
36. Impact of pretransplant mutation status on survival after allogeneic stem cell transplant for acute myeloid leukemia
37. Validation of an electronic algorithm for Hodgkin and non‐Hodgkin lymphoma in ICD‐10‐CM
38. Low Dose Cytoxan Mobilization – a Single Institution Experience
39. Retrospective Single Institution Comparative Study of Outcomes after Post-Transplant Cyclophosphamide for Haploidentical, Matched Unrelated, Mismatched Unrelated and Matched Sibling PB HSCT
40. Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study
41. Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML)
42. Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting
43. Haploidentical (HAPLO) Vs Umbilical Cord Blood (UCB) Allogeneic Hematopoieitc Cell Transplant (ALLO-HCT) in Patients ≥ 60 Years with Hematological Malignancies
44. Elderly do benefit from induction chemotherapy: High dose mitoxantrone-based (“5 + 1”) induction chemotherapy regimen in newly diagnosed acute myeloid leukemia
45. Hematopoeitic Cell Transplant - Comorbidity Index (HCT-CI) Score Is a Useful Tool for Predicting Induction Mortality and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia Patients
46. High Dose Mitoxantrone Based "5+1" Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia
47. 516 - Low Dose Cytoxan Mobilization – a Single Institution Experience
48. 260 - Retrospective Single Institution Comparative Study of Outcomes after Post-Transplant Cyclophosphamide for Haploidentical, Matched Unrelated, Mismatched Unrelated and Matched Sibling PB HSCT
49. Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant
50. Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.